Skip to content
10-K

Annual Report

HeartSciences Inc. HSCS HSCSW

0000950170-25-098326

← back to feed
Filed
Jul 24, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jul 23, 2025 1.93M sh
Shares Diluted FY 2025 · Apr 30, 2025 938.26K sh
Shares Diluted FY 2025 · Apr 30, 2024 352.52K sh
Capex FY 2025 · Apr 30, 2025 $3.16K
Capex FY 2025 · Apr 30, 2024 $64.46K
Operating Cash Flow FY 2025 · Apr 30, 2025 −$7.41M
Operating Cash Flow FY 2025 · Apr 30, 2024 −$6.07M
Cash And Equivalents FY 2025 · Apr 30, 2025 $1.1M
Cash And Equivalents FY 2025 · Apr 30, 2024 $5.81M
Stockholders Equity FY 2025 · Apr 30, 2025 $205.17K
Stockholders Equity FY 2025 · Apr 30, 2024 $7.32M
Stockholders Equity FY 2025 · Apr 30, 2023 $230.56K
Current Liabilities FY 2025 · Apr 30, 2025 $3.7M
Current Liabilities FY 2025 · Apr 30, 2024 $1.75M
Total Liabilities FY 2025 · Apr 30, 2025 $4.02M
Total Liabilities FY 2025 · Apr 30, 2024 $2.19M
Current Assets FY 2025 · Apr 30, 2025 $2.17M
Current Assets FY 2025 · Apr 30, 2024 $7.35M
Total Assets FY 2025 · Apr 30, 2025 $4.22M
Total Assets FY 2025 · Apr 30, 2024 $9.5M
Eps Diluted FY 2025 · Apr 30, 2025 −$9.34
Eps Diluted restated FY 2025 · Apr 30, 2024 −$18.74
Eps Basic FY 2025 · Apr 30, 2025 −$9.34
Eps Basic restated FY 2025 · Apr 30, 2024 −$18.74
Sga Expense FY 2025 · Apr 30, 2025 $3.97M
Sga Expense FY 2025 · Apr 30, 2024 $3.44M
Rd Expense FY 2025 · Apr 30, 2025 $4.39M
Rd Expense FY 2025 · Apr 30, 2024 $2.88M
Net Income FY 2025 · Apr 30, 2025 −$8.77M
Net Income FY 2025 · Apr 30, 2024 −$6.61M
Operating Income FY 2025 · Apr 30, 2025 −$8.35M
Operating Income FY 2025 · Apr 30, 2024 −$6.31M
Gross Profit FY 2025 · Apr 30, 2025 $2.47K
Gross Profit FY 2025 · Apr 30, 2024 $12.52K
Cost Of Revenue FY 2025 · Apr 30, 2025 $1.88K
Cost Of Revenue FY 2025 · Apr 30, 2024 $6.08K
Revenue FY 2025 · Apr 30, 2025 $4.35K
Revenue FY 2025 · Apr 30, 2024 $18.6K